Last reviewed · How we verify
Medium dose TBS-2
At a glance
| Generic name | Medium dose TBS-2 |
|---|---|
| Sponsor | Acerus Pharmaceuticals Corporation |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- PK Study of Testosterone Nasal Gel (TBS-2) in Healthy Premenopausal Women (PHASE1)
- Efficacy and Safety of TBS-2 Testosterone Gel in Women With Acquired Female Orgasmic Disorder (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Medium dose TBS-2 CI brief — competitive landscape report
- Medium dose TBS-2 updates RSS · CI watch RSS
- Acerus Pharmaceuticals Corporation portfolio CI